The phosphodiesterase 5 inhibitor, KJH‐1002, reverses a mouse model of amnesia by activating a cGMP/cAMP response element binding protein pathway and decreasing oxidative damage
Lijun Zhang(Dalian Medical University), Hyun Ok Yang(Bio-Medical Science (South Korea))
Cited by 33
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma
|OncoImmunology|2019|143
Mitophagy in neurological disorders
|Journal of Neuroinflammation|2021|141